PER 0.00% 10.0¢ percheron therapeutics limited

Sarepta gene therapy study missed key target in Duchennes, page-89

  1. 5,245 Posts.
    lightbulb Created with Sketch. 2576
    Most probably hoping his order @0.10 will get filled?

    Finally our SP starting to reflect some of the great achievements from last year, it's very testing holding Co's with very strong fundamentals but SP
    being held down for such long periods.

    Let's see if this is our year...good luck to all Ltermers.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.